OCTOBER 2022LIFE SCIENCES REVIEW5CXO INSIGHTS22Hua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker, Zai LabAccelerating drug development of novel targeted therapies through histology-agnostic oncology clinical trials17Ross Kenyon, Associate Director ­ Modeling, Simulation and Analysis, Regeneron PharmaceuticalsSetting a Culture for Digital Transformation in the Biopharmaceutical IndustryRoman Mathaes, Head of Pharmaceutical Services and Cristina Grigore, LonzaPartnering with a CDMO for successful late phase biologic drug product development and launch2529James Holland, PhD. Senior Medical Writer, Ashfield Health and Kindiya Geghman, PhD, CMPP. Vice President Medical & Scientific Services, Ashfield HealthImmunotherapy in Lung Cancer: Building towards a Patient-Tailored Future35Dr. Sebastian Horn, Vice President, Head of Global Patient Safety & Pharmacovigilance, Teva PharmaceuticalsTransforming Pharmacovigilance Using Technology ­ Help or Hype?SparingVision34SOLUTIONS PROVIDERS IN EUROPE/UK - 2022TOP 10GENOMICSADNTRO23Guillermo Pérez-Solero Monzon(CEO) Puregene33Dr. Gavin George, Cofounder and CEO32Carlos Pedraza, Ph.D., Director of CNS Biology, AlkermesFrom ideation to portfolio program: Innovation vs validation in early drug discoveryGenomix4Life S.r.l.28Maria Ravo, President and R&D Manager, Co-FounderCropTailor24Alf Ceplitis, CEO
< Page 4 | Page 6 >